APOTEX CORP — Paclitaxel Importer Profile
Pharmaceutical Importer · #3 buyer for Paclitaxel · $700.0K import value · 14 shipments · CANADA · DGFT Verified
APOTEX CORP is the #3 importer of Paclitaxel from India with $700.0K in import value and 14 verified shipments. APOTEX CORP holds a 0.8% market share in Paclitaxel imports based in CANADA. The company sources from 1 verified supplier across 13 formulations shipped to 1 country. Overall, APOTEX CORP imports 4 pharmaceutical products worth $37.3M across 4 therapeutic categories.
APOTEX CORP — Paclitaxel Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Paclitaxel to APOTEX CORP?
Verified from 14 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| PANACEA BIOTEC PHARMA LIMITED | $700.0K | 14 | 100.0% |
APOTEX CORP sources Paclitaxel from 1 verified Indian supplier based on 14 customs records. The primary supplier is PANACEA BIOTEC PHARMA LIMITED accounting for 100.0% of imports.
How Does APOTEX CORP Compare to Nearest Paclitaxel Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $787.0K | 16 | $49.2K |
| 2 | OOO"JODAS EXPOIM" | RUSSIA | $750.0K | 15 | $50.0K |
| 3 | APOTEX CORP ★ | CANADA | $700.0K | 14 | $50.0K |
| 5 | OOOJODAS EXPOIM | RUSSIA | $700.0K | 14 | $50.0K |
| 7 | APOTEX INC. | CANADA | $600.0K | 12 | $50.0K |
APOTEX CORP ranks #3 among 959 Paclitaxel importers from India. Average shipment value of $50.0K compared to the market average of $30.0K. The closest competitors by value are NOVADOZ PHARMACEUTICALS LLC and OOO"JODAS EXPOIM".
Where Does APOTEX CORP Import Paclitaxel To?
Destination countries from 14 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $700.0K | 14 | 100.0% |
APOTEX CORP imports Paclitaxel to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $700.0K.
What Paclitaxel Formulations Does APOTEX CORP Import?
| Formulation | Value | Shipments |
|---|---|---|
| PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FORINJECTABLE SUSPENSION 100 MG B/N 907023010 907023011 M/D.09/2023 E/D.08/2025 B | $100.0K | 2 |
| PACLITAXEL PROTEIN BOUND P ARTICLE / ODS / PRODUCT / ITEM FOR | $50.0K | 1 |
| PACLITAXEL (PROTEIN BOUND PARTICLES FOR | $50.0K | 1 |
| PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FORINJECTABLE SUSPENSION 100 MG 907023014M/D.10/2023 E/D.09/2025 | $50.0K | 1 |
| PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FORINJECTABLE SUSPENSION 100 MG B/N.907023012 M/D.10/2023 E/D.09/2025. | $50.0K | 1 |
| PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) 907023016M/D.12/2023 E/D.11/2025VLS | $50.0K | 1 |
| PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) 907023018M/D.12/2023 E/D.11/2025VLS | $50.0K | 1 |
| PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907023019 M/D.01/2024 E/D.12/2025. | $50.0K | 1 |
| PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907023019A M/D.01/2024 E/D.12/2025. | $50.0K | 1 |
| PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907023020 M/D.02/2024 E/D.01/2026. | $50.0K | 1 |
APOTEX CORP imports 13 distinct Paclitaxel formulations from India. The top formulation is PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FO with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Paclitaxel into Canada
What APOTEX CORP and other importers must comply with to import Paclitaxel from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Paclitaxel
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Paclitaxel from India and How Much Does APOTEX CORP Import?
India exported $28.7M worth of Paclitaxel through 4,928 shipments from 319 suppliers to 142 countries, serving 959 buyers globally. APOTEX CORP imports $700.0K of this total, accounting for 0.8% of India's Paclitaxel exports with 14 shipments from CANADA. This is verified from 14 customs shipment records covering 13 distinct formulations.
What Is the Average Order Value for APOTEX CORP's Paclitaxel Imports?
APOTEX CORP's average Paclitaxel order value is $50.0K per consignment, based on 14 shipments totaling $700.0K. APOTEX CORP is based in CANADA and ranks #3 among all Paclitaxel importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Paclitaxel to APOTEX CORP?
APOTEX CORP sources Paclitaxel from 1 verified Indian supplier: PANACEA BIOTEC PHARMA LIMITED ($700.0K, 100.0%). This is based on 14 customs records.
How Does APOTEX CORP Compare to Other Paclitaxel Importers?
APOTEX CORP ranks #3 among 959 Paclitaxel importers from India with a 0.8% market share. The top 3 importers are FRESENIUS KABI DEUTSCHLAND GMBH ($17.2M), J. KNIPPER & COMPANY ($1.9M), MERMISI LLC ($1.1M). APOTEX CORP processed 14 shipments from CANADA.
About APOTEX CORP
APOTEX CORP imports 4 products worth $37.3M. Beyond Paclitaxel, top products include Atorvastatin, Calcium, Protein. View the complete APOTEX CORP profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paclitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX CORP matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX CORP's capped import value divided by total capped export value for Paclitaxel across all Indian exporters.
- 5.Verified Records: This page is backed by 14 individual customs records matching APOTEX CORP importing Paclitaxel, covering 13 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 142+ countries, 959+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paclitaxel Import Data for APOTEX CORP
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX CORP's Paclitaxel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX CORP
Full Company Profile →
4 products · $37.3M total trade · 4 categories
APOTEX CORP × Paclitaxel
Verified from customs records
Company Overview
Top Products by APOTEX CORP
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX CORP.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paclitaxel. For current order-level data, contact TransData Nexus.